Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Can J Occup Ther ; : 84174231190765, 2023 Aug 09.
Artículo en Inglés | MEDLINE | ID: mdl-37554061

RESUMEN

Background. Knowledge about the needs of parents with neurological disorders who take care of young children is limited. Purpose. The overall aim of this qualitative study was to explore the perceived unmet parent needs, current supports, and potential solutions to optimize supports of parents with neurological disorders in early childhood in a Canadian setting. Method. Focus groups and individual interviews with parents (n = 8), spouses (n = 5), rehabilitation clinicians (n = 8), community partners (n = 7), and researchers (n = 7) were conducted with a total of 35 participants recruited using convenience sampling. Inductive iterative thematic analysis was performed. Findings. The participants identified the need for society to officially recognize parenting with disabilities, adjust public policies, increase the scope of public programs, consider child development and family well-being, and have barrier-free communities. Conclusion. Providing customized solutions that will adequately fill perceived service gaps is of utmost importance to address these families' needs.

2.
Encephale ; 49(4S): S33-S41, 2023 Aug.
Artículo en Francés | MEDLINE | ID: mdl-37400332

RESUMEN

Functional neurological disorder (FND) is a common cause of persistent and disabling neurological symptoms. Diagnostic delay may lead to no treatment, inappropriate treatment or even iatrogenic symptoms. Yet, several treatments significantly reduce physical symptoms and improve functioning in FND patients even though not all patients respond to the currently available treatments. This review aims to describe the range of evidence-based rehabilitative and/or psychological therapeutic approaches available for FND patients. The most effective treatments are multidisciplinary and coordinated; using an outpatient or inpatient setting. Building a network of FND-trained healthcare professionals around the patient is an essential aspect of optimal patient management. Indeed, a supportive environment coupled with a collaborative therapeutic relationship improves understanding of FND and appears to help patients engage in appropriate treatments. Patients need to be invested in their own care and have to understand that recovery may depend on their commitment. The conventional treatment combines psychoeducation, physical rehabilitation and psychotherapy (cognitive and behavioral therapy, hypnosis, psychodynamic interpersonal therapy). Early referral of patients to physical therapy is recommended; however, the optimal parameters of treatment, duration and intensity are unknown and seem to vary with the severity and chronicity of symptoms. The goal is to minimize self-awareness by diverting attention or by stimulating automatically generated movements with non-specific and gradual exercises. The use of compensatory technical aids should be avoided as much as possible. Psychotherapeutic management should encourage self-evaluation of cognitive distortions, emotional reactions and maladaptive behaviors while empowering the patient in managing symptoms. Symptom management can use anchoring strategies to fight against dissociation. The aim is to connect to the immediate environment and to enrich one's sensoriality. The psychological interventions should then be adapted to the individual psychopathology, cognitive style and personality functioning of each patient. There is currently no known curative pharmacological treatment for FND. The pharmacological approach rather consists of progressively discontinuing medication that was introduced by default and that could lead to undesirable side effects. Finally, neurostimulation (transcranial magnetic stimulation, transcranial direct current stimulation) can be effective on motor FND.


Asunto(s)
Trastornos de Conversión , Estimulación Transcraneal de Corriente Directa , Humanos , Diagnóstico Tardío , Trastornos de Conversión/diagnóstico , Trastornos de Conversión/terapia , Trastornos Disociativos , Psicoterapia
3.
Praxis (Bern 1994) ; 112(5-6): 329-334, 2023 Apr.
Artículo en Alemán | MEDLINE | ID: mdl-37042404

RESUMEN

Functional Neurological Disorders - A Common but Often Unrecognized Diagnosis Abstract: Functional neurological disorders are frequent and diverse in the clinical presentation. Psychological factors are part of the development and perpetuation of symptoms; psychiatric comorbidities may be present, but are not an obligatory diagnostic criterion. The diagnosis is primarily made on the basis of anamnesis and positive clinical signs. The commonness and reversibility of the symptoms should be emphasised in the clinical consultation, and the positive clinical signs should be demonstrated. Science-based explanations as well as the bio-psycho-social model can help patients to understand their diagnosis, which is relevant for a successful therapeutic outcome. It is recommended to use the neutral and descriptive term "functional neurological disorder". Treatment of the potentially reversible disease will be interdisciplinary and multimodal.


Asunto(s)
Trastornos de Conversión , Enfermedades del Sistema Nervioso , Humanos , Trastornos de Conversión/diagnóstico , Trastornos de Conversión/psicología , Trastornos de Conversión/terapia
4.
Bull Cancer ; 107(1S): S12-S17, 2020 Jan.
Artículo en Francés | MEDLINE | ID: mdl-31202556

RESUMEN

CAR-T cell-related encephalopathy syndrome (CRES) reflects the potential neurotoxicity of this therapeutic approach and must be considered in the presence of any neurological symptom after the infusion of the CAR-T. This is the second most common adverse event under this therapy and its incidence varies between 12 and 55%. The median time of the onset of the first neurologic symptoms is 4days after CAR-T infusion. The duration of CRES symptoms is generally between 2 and 4days, but late CRES may occur. Monitoring and diagnosis of CERS includes clinical exam, magnetic resonance imaging and electroencephalography. In addition to symptomatic treatments, corticosteroids represent the cornerstone of the high-grade CERS treatment. Drugs targeting IL-6 should be restricted to severe forms, especially those associated with cytokine release syndrome. The purpose of this workshop is to provide practical help in dealing with this complication.


Asunto(s)
Inmunoterapia Adoptiva/efectos adversos , Síndromes de Neurotoxicidad/terapia , Corticoesteroides/uso terapéutico , Adulto , Anticonvulsivantes/uso terapéutico , Niño , Síndrome de Liberación de Citoquinas/etiología , Síndrome de Liberación de Citoquinas/terapia , Manejo de la Enfermedad , Humanos , Incidencia , Neuroimagen , Síndromes de Neurotoxicidad/diagnóstico , Síndromes de Neurotoxicidad/epidemiología , Síndromes de Neurotoxicidad/etiología , Factores de Riesgo , Terapia Recuperativa , Índice de Severidad de la Enfermedad , Síndrome
5.
Pan Afr Med J ; 32: 108, 2019.
Artículo en Francés | MEDLINE | ID: mdl-31223398

RESUMEN

Neurological disorders secondary to vitamin B12 deficiency are polymorphic and diverse. There have been very few studies conducted in the Moroccan as well as in the African population. This study aims to describe the clinical, paraclinical, evolutionary features of neurological manifestations in patients with vitamin B12 deficiency within the Department of Neurology at the Moulay Ismail Military Hospital, Meknes over a period of 18 years (1999-2017). The study involved 06 women and 23 men, with an average age of 57 years. The mean time between symptom onset and diagnosis was 3 months. Neurological manifestation was indicative of vitamin B12 deficiency in 100% of cases. The average hemoglobin level was 10 g/dl, the mean corpuscular volume was 115 fl. Medullary megaloblastosis and atrophic gastritis were found in 95% and 90% of cases respectively. Regular electromyography (EMG), electroencephalography (EEG) and visual evoked potentials (VEP) showed subclinical peripheral and optic neuropathies. In 20 cases they were caused by Biermer's anemia. All the patients received parenteral Vitamin B12 with good outcome. These results demonstrate the importance of early diagnosis in patients with a potentially serious neuropsychiatric condition as well as of rapid substitution treatment which is the only therapeutic option to secure a good outcome.


Asunto(s)
Anemia Perniciosa/epidemiología , Enfermedades del Sistema Nervioso/epidemiología , Deficiencia de Vitamina B 12/complicaciones , Vitamina B 12/administración & dosificación , Anciano , Anemia Perniciosa/diagnóstico , Anemia Perniciosa/etiología , Electroencefalografía/métodos , Electromiografía/métodos , Potenciales Evocados Visuales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Marruecos/epidemiología , Enfermedades del Sistema Nervioso/diagnóstico , Enfermedades del Sistema Nervioso/etiología , Enfermedades del Nervio Óptico/diagnóstico , Enfermedades del Nervio Óptico/epidemiología , Enfermedades del Nervio Óptico/etiología , Estudios Retrospectivos , Factores de Tiempo , Deficiencia de Vitamina B 12/diagnóstico
6.
Rev Med Interne ; 39(3): 155-160, 2018 Mar.
Artículo en Francés | MEDLINE | ID: mdl-29274796

RESUMEN

BACKGROUND: Compliance with treatment is very important for patients who suffer from Wilson's disease, a rare genetic disorder. They can benefit a long-life and effective treatment. The purpose of our study is to identify the level of compliance in Wilson's disease patients and features associated with compliance as well. METHODS: This is a prospective study carried out in the National Reference Center for Wilson Disease (based in Paris and Lyon) over a 8 months period. Patients were evaluated on the first (M0) and last month (M8) with a questionnaire evaluating the number of missed treatment doses, a self-questionnaire collecting the reasons for non-compliance, and analogic scales analyzing the doctor-patient relationship and their behavior towards the treatment. The severity of depression symptoms was investigated by the Beck Depression Inventory (BDI). A detailed phone call interview was conducted by a psychologist every two months to evaluate their compliance and feeling. RESULTS: Thirty-nine patients were included. The mean age of patients was 34 years (±9.9). At M0, 84.6% had a poor compliance with treatment. They were diagnosed more recently (P=0.049) with a higher proportion involving neurological disorders (P=0.007). Age, the type of treatment and the quality of the doctor-patient relationship were not associated with the outcome; 38.5% suffered from depressive symptoms. At M8, 56.8% of patients were poor compliants and 21.6% presented depressive symptoms. CONCLUSION: Wilsons's disease patients have important problems with compliance, without necessary being depressed. A close follow-up may help them become compliant, particularly those with neurological symptoms.


Asunto(s)
Cuidados Posteriores , Degeneración Hepatolenticular/terapia , Grupo de Atención al Paciente , Cooperación del Paciente , Adulto , Cuidados Posteriores/métodos , Cuidados Posteriores/organización & administración , Depresión/epidemiología , Depresión/etiología , Femenino , Estudios de Seguimiento , Francia/epidemiología , Degeneración Hepatolenticular/complicaciones , Degeneración Hepatolenticular/epidemiología , Humanos , Masculino , Persona de Mediana Edad , Grupo de Atención al Paciente/organización & administración , Grupo de Atención al Paciente/normas , Cooperación del Paciente/estadística & datos numéricos , Resultado del Tratamiento , Adulto Joven
7.
Can J Occup Ther ; 85(5): 365-377, 2018 Dec.
Artículo en Francés | MEDLINE | ID: mdl-30599776

RESUMEN

BACKGROUND.: Although community integration (CI) is the ultimate goal of rehabilitation, it is rarely achieved in clinical settings. PURPOSE.: The purpose of this study was to (a) synthesize the state of occupational therapy knowledge related to CI for people with neurological issues and to (b) illustrate how CI is conceptualized within the literature. METHOD.: A scoping review was completed using two reviewers, resulting in the selection of 47 articles pertaining to four study populations. Themes common across all client populations were identified through content analysis, and an iterative synthesis was used to analyse the evolution of knowledge. FINDINGS.: The selected articles covered craniocerebral trauma ( n = 21, 9 experimental categories [EXP]), medullar injuries ( n = 11, 4 EXP), cerebrovascular injuries ( n = 9, 4 EXP), and multiple sclerosis ( n = 4, 1 EXP). CI was used interchangeably with the term social participation. Fifty-one percent of the articles defined CI solely as part of a measurement tool, and 10% did not provide a definition of CI. The physical dimension of CI had been studied more frequently than the social and psychological dimensions. IMPLICATIONS.: Innovative practices should work to enable community inclusion and full citizenship to support the long-term enablement.


DESCRIPTION.: Bien que l'intégration communautaire (IC) constitue l'ultime but en réadaptation, elle s'actualise rarement en clinique. BUT.: Le but de cette étude était de (a) synthétiser l'état des connaissances ergothérapiques liées à l'IC auprès de personnes atteintes d'un trouble neurologique et (b) dresser un portrait de l'opérationnalisation du concept d'IC au sein de ces écrits. MÉTHODOLOGIE.: Un examen de la portée fut réalisé en double sélection pour ultimement retenir 47 écrits, touchant quatre populations sélectionnées. Les thématiques propres à l'ensemble des clientèles ont été dégagées par analyse de contenu et les constats touchant l'évolution des connaissances ont fait l'objet de synthèses itératives. RÉSULTATS.: Les écrits retenus concernent le traumatisme craniocérébral ( n = 21, 9 devis expérimentaux [EXP]), les blessures médullaires ( n = 11, 4 EXP), l'accident vasculaire cérébral ( n = 9, 4 EXP) et la sclérose en plaques ( n = 4, 1 EXP). L'IC est employée de façon interchangeable avec la participation sociale: 51 % des écrits définissent l'IC uniquement à partir d'un outil de mesure et 10 % n'offrent aucune définition de l'IC. La dimension physique de l'IC est plus étudiée que les dimensions sociale et psychologique. CONSÉQUENCES.: Les pratiques innovantes doivent viser l'affiliation et l'exercice d'une pleine citoyenneté afin de soutenir une habilitation durable.


Asunto(s)
Lesiones Encefálicas/rehabilitación , Integración a la Comunidad , Personas con Discapacidad/rehabilitación , Esclerosis Múltiple/rehabilitación , Terapia Ocupacional , Humanos
8.
Encephale ; 41(6): 550-5, 2015 Dec.
Artículo en Francés | MEDLINE | ID: mdl-26345354

RESUMEN

Biermer disease or pernicious anemia is an autoimmune atrophic gastritis characterized by the lack of secretion of gastric intrinsic factor. This leads to an insufficient absorption of vitamin B12 in the ileum. Clinical manifestations are mainly hematologic. Neuropsychiatric manifestations are known but are less frequent especially early in the disease. Inaugural neuropsychiatric arrays are rare and various thus making diagnosis difficult. In this article, we report through two clinical cases different neuropsychiatric manifestations revealing pernicious anemia. Mrs. C.O., aged 56, presented after surgery for gallstones, an acute psychiatric array associated with gait disorders. She had no history of neurological or psychiatric problems. The psychiatric interview revealed delirious syndrome, depressive symptoms and anxiety. Neurological examination noted a flaccid paraplegia with peripheral neuropathic syndrome and myoclonus in the upper limbs. At the full blood count, a macrocytosis (VGM: 112.2fl) without anemia was found. The level of vitamin B12 in the blood was low. Cerebro-spinal MRI was suggestive of a neuro-Biermer and showed hyper signal in the cervical cord on T2-weighted sagittal section. In axial section, hyper signal appears at the posterior columns in the form of V. There were no brain abnormalities. A sensorimotor axonal polyneuropathy was diagnosed. The patient received vitamin B12 intramuscularly for ten days associated with neuroleptic treatment. Mrs. R.M., aged 40, was brought to the psychiatry consultation for acute behavioral disorders progressively worsening over a month. An anxiety syndrome, depressive syndrome and delirious syndrome were identified. Neurological examination showed a posterior cordonal syndrome with quadripyramidal syndrome. Full blood count showed a macrocytic anemia. Serum B12 level was collapsed. Cerebro-spinal MRI was normal. She received vitamin B12 with clinical and biological improvement. Features of pernicious anemia vary according to studies and age range. Digestive and hematological manifestations are well known. Neurological and psychiatric manifestations of pernicious anemia were also described in the early literature. They can be the initial symptoms or the only ones. However, inaugural neuropsychiatric features are often unrecognized. The most common psychiatric symptoms were depression, mania, psychotic symptoms, cognitive impairment and obsessive compulsive disorder. Neurological involvement includes mainly combined spinal sclerosis, peripheral neuropathy and dementia. Cerebellar ataxia and movement disorders are reported less often. Severity of neuropsychiatric features and therapeutic efficacy depends on the duration of signs and level of B12 deficiency. Macrocytic anemia may lack. Neuropsychiatric manifestations could be isolated or be the first manifestation of vitamin deficiency and occur without any hematological or gastrointestinal context. Pernicious anemia and serum B12 assay should be discussed in all patients with organic mental disorders, atypical psychiatric symptoms and fluctuation of symptomatology. Nevertheless, B12 level could be normal in genuine pernicious anemia diseases and macrocytic anemia may lack. Substitutive vitaminotherapy is required when diagnosis is strongly suspected and etiologic assessment is negative.


Asunto(s)
Anemia Perniciosa/diagnóstico , Trastornos de Ansiedad/etiología , Depresión/etiología , Deficiencia de Vitamina B 12/diagnóstico , Adulto , Anemia Perniciosa/psicología , Antipsicóticos/uso terapéutico , Trastornos de Ansiedad/tratamiento farmacológico , Delirio/tratamiento farmacológico , Delirio/etiología , Femenino , Trastornos Neurológicos de la Marcha/etiología , Humanos , Imagen por Resonancia Magnética , Persona de Mediana Edad , Deficiencia de Vitamina B 12/psicología
9.
J Mal Vasc ; 40(1): 37-41, 2015 Feb.
Artículo en Francés | MEDLINE | ID: mdl-25554653

RESUMEN

Neurological disorders are rare complications of foam sclerotherapy. Visual disturbances and headache are the most commonly reported events and are thought to be equivalent to migraine with aura. Exceptionally, strokes have been reported. Papillary fibroelastoma is a rare cardiac tumor, which may embolize in cerebral arteries. We report the case of a patient in whom neurological disorders occurred during a session of foam sclerotherapy, and led to the discovery of a cardiac fibroelastoma.


Asunto(s)
Fibroma/diagnóstico , Neoplasias Cardíacas/diagnóstico , Enfermedades del Sistema Nervioso/etiología , Escleroterapia/efectos adversos , Escleroterapia/métodos , Femenino , Fibroma/cirugía , Neoplasias Cardíacas/cirugía , Humanos , Imagen por Resonancia Magnética , Persona de Mediana Edad
10.
Neurophysiol Clin ; 44(4): 339-42, 2014 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-25306074

RESUMEN

Functional neurological disorders, also known as conversion disorder, are unexplained neurological symptoms. These symptoms are common and can be associated with significant consequences. This review covers the neuroimaging literature focusing on functional motor symptoms including motor functioning and upstream influences including self-monitoring and internal representations, voluntariness and arousal and trauma.


Asunto(s)
Encéfalo/fisiopatología , Trastornos de Conversión/complicaciones , Trastornos de Conversión/fisiopatología , Neuroimagen , Nivel de Alerta/fisiología , Humanos , Trastornos del Movimiento/complicaciones , Trastornos del Movimiento/fisiopatología
11.
Mali méd. (En ligne) ; 24(3): 43-46, 2009. tables
Artículo en Francés | AIM (África) | ID: biblio-1265597

RESUMEN

Objectifs :Decrire les caracteristiques epidemiologiques; et cliniques des AVC; de l'epilepsie et de l'eclampsie. Observes au cours de la grossesse et du post-partum. Methode : il s'agit d'une etude de prospective sur 19 mois allant d'Aout a 2005 a Fevrier 2007; qui s'est deroulee dans le service de neurologie du CHU du Point-G et dans le centre de sante de reference de la commune V du district de Bamako. Etaient concernees par ce travail toutes les femmes en age de procreer ( 15 a 45 ans) consentantes; ayant ete examinees et/ou hospitalisees pour troubles neurologiques apparus pendant la grossesse et /ou les six mois suivant l'accouchement; dans nos differents site d'etude. Resultat : Au cours de notre etude nous avons recrute 20 patientes en consultation externe (sur 629 ) et 17 patientes en hospitalisation ( sur 629 ); soit au total 37 malades ( sur 6914) qui repondaient a nos criteres. La frequence globale des troubles neurologiques associes a la grossesse et au postpartum etait de 3;02. La tranche d'age la plus representee etait celle de15 a 25 ans avec 48;70des cas. Le diagnostic d'epilepsie a ete retenu chez 51;40de nos patientes ; l'AVC et l'eclampsie ont occupe les deuxieme et troisieme rangs avec les taux respectifs de 37;80et 10;80. L'evolution de la grossesse etait en generale favorable ; les accouchements ont ete dans la plupart des cas; eutociques; nous avons enregistre 1 seul cas de cesarienne


Asunto(s)
Neurología , Periodo Posparto , Accidente Cerebrovascular , Embarazo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA